Get access

Spermatogonial stem cells: Mouse and human comparisons

Authors

  • Martin Dym,

    Corresponding author
    1. Department of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, 3900 Reservoir Road, NW, Washington, DC
    • Department of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, 3900 Reservoir Road NW, Washington, DC 20057
    Search for more papers by this author
  • Maria Kokkinaki,

    1. Department of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, 3900 Reservoir Road, NW, Washington, DC
    Search for more papers by this author
  • Zuping He

    1. Department of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, 3900 Reservoir Road, NW, Washington, DC
    Search for more papers by this author

Abstract

Spermatogonial stem cells (SSCs) have unique characteristics in that they produce sperm that transmit genetic information from generation to generation and they can be reprogrammed spontaneously to form embryonic stem (ES)-like cells to acquire pluripotency. In rodents, it is generally believed that the A-single (As) is the stem cell population, whereas the A-paired (Apr) and A-aligned (Aal) represent the progenitor spermatogonial population. The A1 to A4 cells, intermediate, and type B spermatogonia are considered differentiated spermatogonia. In human, very little information is available about SSCs, except for the earlier work of Clermont and colleagues who demonstrated that there are two different types of A spermatogonia, the Adark and Apale spermatogonia. The Adark spermatogonia were referred to as the reserve stem cells, whereas the Apale were considered the renewing stem cells. In this review, we outline several spermatogonial renewal schemes for both rodents and primates, including man. We also compare phenotypic markers for spermatogonia/spermatogonial stem cells in rodents and humans and address SSC potential and therapeutic application. Birth Defects Research (Part C) 87:27–34, 2009. © 2009 Wiley-Liss, Inc.

Ancillary